Delivery Order SPE2DB20D2104-SPE2DB24FS44L
Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $5.5K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Advair HFA 45-21 MCG inhalers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract has a ceiling value of $1,335.71 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 115-21 mcg inhalers. The $25,074.96 firm fixed-price delivery order contract has a completion date of May 6, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM pharmaceutical products to the Defense Logistics Agency (DLA). The single-award Indefinite Delivery Contract (IDC) with the prime contractor, Amerisourcebergen Drug Corp, is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $7,845.98, is a firm-fixed-price delivery order with a final completion date of February 6, 2024. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Advair HFA 230-21 mcg inhalers to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The 12-month, firm fixed price contract, valued at $5,886.79, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG inhalers, valued at $3,136.93, to the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is a delivery order contract with a firm fixed price, with a completion date of February 13, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) under a Delivery Order valued at $6,654.52. The contract provides for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a period of performance through February 28, 2024. The contract is a Firm Fixed Price type and was awarded without a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Advair HFA 115-21 MCG Inhaler 12GM. The $4,571.62 firm fixed-price delivery order has an ultimate completion date of January 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC...
- This federal contract award is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., has a ceiling value of $20,360.53 and runs through March 7, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award, valued at $11,679.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG inhalers, a pharmaceutical product used for the treatment of respiratory conditions. This is a firm-fixed-price delivery order contract with a completion date of February 13, 2024. The contract was awarded on an open competition basis, with no set-aside designations....